Equillium raises $35 million from RA Capital Management

Go back to Equillium raises $35 million from RA Capital Management

Equillium Announces $35 Million Financing with RA Capital Management

March 13, 2026 8:00 AM EDT

Capital strengthens the advancement of EQ504 through key clinical milestones

Anticipated net proceeds, along with existing cash and cash equivalents, expected to extend cash runway into 2029

LA JOLLA, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Equillium or the Company) (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders,... More